ANZCA’s statement on desflurane supports the continued education and actions to reduce usage.

Justification for the statement from the Faculty of Pain Medicine on medicinal cannabis with reference to its use in the management of patients with chronic non-cancer pain.

The college has signed an historic joint statement to reduce the health system’s carbon emissions.

A multidisciplinary document development group (DDG) has developed a statement on persistent pelvic pain and endometriosis. The document was produced after an extensive review of the current evidence.

The ANZCA Course in Perioperative Medicine enables specialist doctors, such as anaesthetists, surgeons, physicians, intensivists, and general practitioners to enhance their skills and knowledge in perioperative medicine​.

Taking part in our educational, advocacy, research and leadership activities enables fellows to play an active role in shaping the future of our professions. Find out how you can get involved.

ANZCA has an experienced communications team that proactively engages with the media to highlight the important work of our anaesthetists and pain specialists. This includes sharing our latest evidence-based research and patient safety initiatives. We also actively encourage m...

ANZCA Council and the FPM Board are disappointed that the Voice to Parliament was not supported in the Australian government referendum.

ANZCA and ASA joint update statement about IV fluid supplies